INTERNATIONAL PATENT: ADAPTIVE BIOTECHNOLOGIES CORPORATION FILES APPLICATION FOR "AGENTS AND METHODS FOR PREVENTING OR INHIBITING ADAPTIVE IMMUNE RESPONSES ASSOCIATED WITH MULTIPLE SCLEROSIS"

GENEVA, March 10 -- ADAPTIVE BIOTECHNOLOGIES CORPORATION (1165 Eastlake Avenue EastSeattle, Washington 98102) filed a patent application (PCT/US2024/044928) for "AGENTS AND METHODS FOR PREVENTING OR INHIBITING ADAPTIVE IMMUNE RESPONSES ASSOCIATED WITH MULTIPLE SCLEROSIS" on Aug 31, 2024. With publication no. WO/2025/050088, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MOORE, Amanda (c/o Adaptive Biotechnologies Corporation1165 Eastlake Avenue EastSeattle, Washington 98102), HARRIS, Rebecca (c/o Adaptive Biotechnologies...